• MédiMabs, your “Go To” supplier for top quality antibodies and services.

    MédiMabs, your “Go To” supplier for top quality antibodies and services.

  • MédiMabs' research scientists,

    MédiMabs' research scientists,

    with specialized antibody experience, work with you from your problem definition to proven results.

  • Whether you need

    Whether you need

    access to antibody-specific tools, expert peptide designor synthesis of new monoclonal or polyclonal antibodies, from existing or newly discovered proteins, like a boutique, every solution is custom fitted through a scientific dialog to your needs.

Featured Services

We are dedicated to providing high quality antibodies, scientific excellence and personalized services

MédiMabs is recognized and solicited for the personalized services they offer for the development of monoclonal antibodies. MédiMabs’ aim is to generate antibodies that recognize not only the immunizing agent but the entire target protein so as to ensure it functions in client’s application in the most satisfactory manner.

MédiMabs’ standard protocol for monoclonal antibodies production requires approximately 4 to 6 months to be completed. The process is divided in 4 phases with phase 2 being the Go/No Go phase at which point the project can be aborted should the pre-fusion screening does not meet client’s expectations.

Due the lack of a suitable fusion partner, rabbit monoclonal antibodies are much more difficult to develop compared to mouse or rat’s. MédiMabs circumscribes this problem by offering the Recombinant Monoclonal Antibody Technology (RMAT). This innovative technology screens the immune repertoire of the rabbit creating the power to select the desired antibody directly from B cells.

The RMAT technology provides:

  • High affinity antibodies without the traditional cell fusion step
  • Recombinant antibody ensuring preservation of genetic information
  • Both a monoclonal and polyclonal end product
  • Production of valuable antibodies against different epitopes on the same antigen

Chickens immune system often recognizes mammalian proteins as being foreign which results in a strong immune response. The greater the phylogenetic gap between the immunized animal and the source of the antigen the immune response.

IgY antibodies are very good to be in combination with mouse, rats and rabbit antibodies in double-staining assays. Secondary antibodies against chicken IgY’s don’t cross react with mammalian IgG’s since the IgY molecule is quite different antigenically from the mammalian IgG.

To overcome certain difficulties posed by lipids present at the IgY preparation, a trade secret technology is used to ensure complete delipidation.

COMING SOON

Promotions

MédiMabs frequently offer special promotions on its collection of monoclonal and polyclonal antibodies.

Find out here how you can receive an automatic 20% saving off the list price.

Limited time offer: Get 10% on the generation of monoclonal antibodies

MédiMabs' promotions are updated every month, be sure to come back and visit us again!

Services

MédiMabs offers top high quality custom antibodies production and other related services tailored to your highly specific needs, scientific challenges and applications. Our experience and applied technical excellence allow us to provide our clients complete support for all aspects of custom antibodies production and related issues. In addition to our custom production services, our diverse custom service range includes: peptide design and synthesis, antibody purification, ascites, large scale production among other antibody-related services.

Research & Development: Antibody Pipeline

MédiMabs has a commitment with the research community: to regularly feed its antibody catalog with new and exclusive high quality well validated and characterized monoclonals and polyclonals antibodies. MédiMabs’ expert technical staff is further guided by a scientific advisory committee composed of world-class scientists and researchers who are leading authorities in areas such as immunology, neurosciences, oncology and other medical research fields.

MÉDIMABS' Approach is Refreshing and Timely in Today's Market

  • Scientific excellence
  • Scientific dialog
  • Boutique-style response
  • Colleague style
  • Personalized services
  • Partnering opportunities
  • Regulated practices